A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis
John H. Noseworthy(Mayo Clinic), Moses Rodriguez(Mayo Clinic in Arizona), Tanya M. Petterson(Mayo Clinic), Jacqueline A. Leavitt(Mayo Clinic), D. M. Wingerchuk(Mayo Clinic), D. Sneve(Mayo Clinic), Peter C. O’Brien(University Hospital Crosshouse), Raymond G. Auger(Mayo Clinic), W. K. Peterson(Mayo Clinic), Shelley A. Cross(Mayo Clinic), L. Stevens(Mayo Clinic), Brian G. Weinshenker(Mayo Clinic in Arizona), Jennifer A. Weis(Mayo Clinic), David W. Dodick(New York Academy of Medicine)
Cited by 164
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k